Insider Transactions Reported by 25 Insiders of Cartesian Therapeutics, Inc.

Symbol
RNAC on Nasdaq
Location
Frederick, MD

Insiders trading volume in the past year

Cartesian Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Elizabeth Hoge 10%+ Owner $121,140,159 11 Oct 2024
Timothy A. Springer Director, 10%+ Owner $81,409,176 +$2,893,671 +3.7% 02 Jan 2026
Murat Kalayoglu Director, 10%+ Owner $42,820,934 02 Jan 2026
Carsten Brunn President and CEO, Director $2,206,377 -$162,077 -6.8% 06 Jan 2026
Michael Singer Director $1,478,716 02 Jan 2026
Metin Kurtoglu Chief Technology Officer $1,110,427 03 Jan 2025
PETER G. TRABER Chief Medical Officer $930,762 25 Sep 2023
Lloyd P. Johnston Chief Operations Officer $922,211 04 Jan 2023
Emily English Chief Operations Officer $835,211 02 Jan 2026
Blaine Davis Chief Financial Officer $826,684 -$72,227 -8% 06 Jan 2026
Aymeric Sallin Director $546,800 02 Jan 2024
TIMOTHY C. BARABE Director $487,524 +$205,797 +73% 02 Jan 2026
Takashi Kei Kishimoto Chief Scientific Officer $464,151 30 May 2023
Kevin Tan Chief Financial Officer $427,220 03 Jan 2022
Milos Miljkovic Chief Medical Officer $401,134 -$24,367 -5.7% 06 Jan 2026
Christopher M. Jewell Chief Scientific Officer $255,114 10 Jan 2025
ZENNER PATRICK J Director $115,792 02 Jan 2026
Nishan M. DeSilva Director $102,204 02 Jan 2026
Kemal Malik Director $100,235 02 Jan 2026
GORAN ANDO Director $59,250 02 Jan 2023
CARRIE SMITH COX Director $57,896 02 Jan 2025
June Ann Seymour Chief Accounting Officer $54,925 02 Jan 2026
Adrian Ion Bot Director $44,080 16 Dec 2025
Ann K. Donohue VP Finance $8,625 27 May 2021
Scott Dunseth Myers Director 13 Nov 2023

Recent Insider Transactions by Companies or Individuals for Cartesian Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.